$4.70
+0.0100 (+0.213%)
At Close: Feb 07, 2020
OmniAb Announces Completion of Spin-Off and Business Combination
04:01pm, Tuesday, 01'st Nov 2022
EMERYVILLE, Calif.
SAN DIEGO--(BUSINESS WIRE)--Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI™ (teclistamab)
OmniAb Business Combination Approved by APAC Shareholders
05:00pm, Monday, 24'th Oct 2022
SAN DIEGO--(BUSINESS WIRE)--OmniAb Business Combination Approved by APAC Shareholders
Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
09:00am, Monday, 03'rd Oct 2022
EMERYVILLE, Calif.--(BUSINESS WIRE)-- #earnings--Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
Ligand Reports Second Quarter 2022 Financial Results
04:01pm, Monday, 08'th Aug 2022
EMERYVILLE, Calif.--(BUSINESS WIRE)-- #earnings--Ligand Reports Second Quarter 2022 Financial Results
Sign In
Buy AHPA